Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue and ghrelin receptor agonist. Laboratory research involving Ipamorelin investigates its potential role in stimulating endogenous growth hormone release, influencing metabolism, and modulating appetite-related pathways. Studies indicate that Ipamorelin may affect growth hormone secretion without significantly altering cortisol or prolactin levels.
Scientific investigations continue to explore Ipamorelin’s potential impacts on anabolic processes, muscle growth, metabolic efficiency, and physiological regulation in controlled laboratory environments.
Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Ipamorelin outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C38H49N9O5
- Molecular Weight: 711.9 g/mol
- CAS Number: 170851-70-4
Source: PubChem